Long-term Safety of Vedolizumab for Inflammatory Bowel Disease Long-term Safety of Vedolizumab for Inflammatory Bowel Disease
This paper details the final results from the GEMINI study, which evaluated the long-term safety of vedolizumab in patients with ulcerative colitis or Crohn ' s disease.Alimentary Pharmacology & Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
More News: Crohn's Disease | Drugs & Pharmacology | Gastroenterology | Health | Inflammatory Bowel Disease | Study | Ulcerative Colitis